A Single Ascending Dose Trial of CVL-936 in Healthy Subjects
Clinical trial NCT04232878 · TERMINATED
Trial details
- NCT number
- NCT04232878
- Sponsor
- Cerevel Therapeutics, LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-16
- Primary completion
- 2020-03-06
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.